Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT00613626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Etoposide
DRUG: Placebo
DRUG: ZD6474

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]